ArticleIET systems biology2020
Adaptive back-stepping cancer control using Legendre polynomials.
Article in IET systems biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 6 citations in OpenAlex.
- Pseudo-spectral method for controlling the drug dosage in cancer.IET systems biology · 2020Article
- Designing a Resilient Controller for Cancer Immunotherapy: Application to a Fractional-Order Tumour-Immune Model.IET systems biologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Here, a model-free controller for cancer treatment is presented. The treatment objective is to find a proper drug dosage that can reduce the population of tumour cells. Recently, some solutions have been proposed according to the control theory. In these approaches, based on the mathematical description of the number of effector cells, tumour cells, and concentration of the interleukin-2 (IL-2), a non-linear controller is designed. Here, based on the back-stepping design procedure and function approximation property of Legendre polynomials, a novel controller for MIMO cancer immunotherapy is presented. In fact, Legendre polynomials play the role of uncertainty estimation and compensation. In comparison with other uncertainty estimators such as neural networks, Legendre polynomials have simpler structure. Thus, the contribution of this study is simplifying the design procedure and reducing the controller computational load in comparison with Neuro-Fuzzy controllers. The resulting closed-loop system is capable of overcoming various uncertainties. Simulation results verify the efficiency of the proposed method in the fast reduction of tumour cells. Moreover, a comparison between the performance of Legendre polynomials and a radial basis functions neural network (RBFN) is presented.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.